Gerrit Hauck

Gerrit Hauck, Ph.D., has been Chief Technology Officer of Basilea since 2018. He is a member of the Management Committee of Basilea.

Mr. Hauck joined Basilea from Sanofi, where he held various technical operations and management functions during his 24-year career at Sanofi and its predecessor companies, including formulation development, plant management and global CMC leadership. Most recently, he was cluster head synthetic molecules, overseeing most of Sanofi’s technical development programs for synthetic molecules from pre-clinical candidates to launch. Since January 2012 he was a member of Sanofi’s research stage gate committee, which was responsible for the transition of candidate molecules from research into development.

Mr. Hauck graduated as a pharmacist from the University of Heidelberg and holds a Ph.D. from Saarland University.